glycine has been researched along with Colonic Neoplasms in 35 studies
Colonic Neoplasms: Tumors or cancer of the COLON.
Excerpt | Relevance | Reference |
---|---|---|
" Here, we evaluated the anti-inflammatory Trimethylglycine and the Signal transducer and activator of transcription (STAT6) inhibitor AS1517499, as possible adjuvants to 5-FU in already established cancers, using a model of colitis-associated colon cancer (CAC)." | 7.96 | Use of STAT6 Phosphorylation Inhibitor and Trimethylglycine as New Adjuvant Therapies for 5-Fluorouracil in Colitis-Associated Tumorigenesis. ( Beristain-Terrazas, DL; Callejas, BE; Chirino, YI; Delgado-Buenrostro, NL; García-Castillo, V; Gutierrez-Cirlos, EB; León-Cabrera, SA; Mendoza-Rodríguez, MG; Meraz-Ríos, MA; Pérez-Plasencia, C; Rodríguez-Sosa, M; Sánchez-Barrera, CÁ; Terrazas, LI; Vaca-Paniagua, F, 2020) |
"alpha-Methylacyl-CoA racemase (AMACR), an enzyme involved in oxidation of branched chain fatty acids and cholesterol metabolites, as well as ibuprofen metabolism, is overexpressed in colorectal adenomas and cancer." | 5.12 | Variants in the alpha-Methylacyl-CoA racemase gene and the association with advanced distal colorectal adenoma. ( Chatterjee, N; Daugherty, SE; Fallin, MD; Hayes, RB; Huang, WY; Isaacs, WB; Platz, EA; Shugart, YY; Welch, R, 2007) |
" Here, we evaluated the anti-inflammatory Trimethylglycine and the Signal transducer and activator of transcription (STAT6) inhibitor AS1517499, as possible adjuvants to 5-FU in already established cancers, using a model of colitis-associated colon cancer (CAC)." | 3.96 | Use of STAT6 Phosphorylation Inhibitor and Trimethylglycine as New Adjuvant Therapies for 5-Fluorouracil in Colitis-Associated Tumorigenesis. ( Beristain-Terrazas, DL; Callejas, BE; Chirino, YI; Delgado-Buenrostro, NL; García-Castillo, V; Gutierrez-Cirlos, EB; León-Cabrera, SA; Mendoza-Rodríguez, MG; Meraz-Ríos, MA; Pérez-Plasencia, C; Rodríguez-Sosa, M; Sánchez-Barrera, CÁ; Terrazas, LI; Vaca-Paniagua, F, 2020) |
"HCT-116 colon cancer xenografts lacking mitochondrial 1C pathway activity generate the 1C units required for growth by cytosolic serine catabolism." | 1.43 | Reversal of Cytosolic One-Carbon Flux Compensates for Loss of the Mitochondrial Folate Pathway. ( Chen, L; Ducker, GS; Esposito, M; Ghergurovich, JM; Kang, Y; Morscher, RJ; Rabinowitz, JD; Teng, X, 2016) |
"Ixazomib treatment resulted in significant metabolic regulation, and some of these changes were specific to KRAS WT tumors." | 1.42 | KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism. ( Amidon, B; Bannerman, B; Berger, AJ; Bernard, H; Chattopadhyay, N; Donelan, J; Galvin, K; Garnsey, J; Hales, P; Hather, G; Jordan, K; Koenig, E; Maldonado Lopez, A; Manfredi, M; Rhodes, N; Stringer, B; Tirrell, S; Xia, C; Yang, Y, 2015) |
"The in vivo anticancer activity study with HT-29 colon cancer cell xenografted mice showed that the intratumorally injected PCC hydrogel inhibited the tumor growth more effectively relative to CPT alone (-29% vs." | 1.38 | Injectable poly(organophosphazene)-camptothecin conjugate hydrogels: synthesis, characterization, and antitumor activities. ( Cho, JK; Chun, C; Kuh, HJ; Song, SC, 2012) |
"In two ulcerative colitis patients, a mutation was found in the Ki-ras gene (Gly --> Asp 12 and Gly --> Val 12), and in one patient, a mutation in exon 5 of the p53 gene." | 1.30 | Detection of Ki-ras mutations by PCR and differential hybridization and of p53 mutations by SSCP analysis in endoscopically obtained lavage solution from patients with long-standing ulcerative colitis. ( Heinzlmann, M; Lang, SM; Loeschke, K; Stratakis, DF; Teschauer, W, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (14.29) | 18.7374 |
1990's | 9 (25.71) | 18.2507 |
2000's | 8 (22.86) | 29.6817 |
2010's | 12 (34.29) | 24.3611 |
2020's | 1 (2.86) | 2.80 |
Authors | Studies |
---|---|
Mendoza-Rodríguez, MG | 1 |
Sánchez-Barrera, CÁ | 1 |
Callejas, BE | 1 |
García-Castillo, V | 1 |
Beristain-Terrazas, DL | 1 |
Delgado-Buenrostro, NL | 1 |
Chirino, YI | 1 |
León-Cabrera, SA | 1 |
Rodríguez-Sosa, M | 1 |
Gutierrez-Cirlos, EB | 1 |
Pérez-Plasencia, C | 1 |
Vaca-Paniagua, F | 1 |
Meraz-Ríos, MA | 1 |
Terrazas, LI | 1 |
Engür, S | 1 |
Dikmen, M | 1 |
Farhangian, H | 1 |
Eslami Moghadam, M | 1 |
Divsalar, A | 1 |
Rahiminezhad, A | 1 |
Zhao, Y | 1 |
Wu, Z | 1 |
Zhang, Y | 1 |
Zhu, L | 1 |
Gonsalves, WI | 1 |
Mahoney, MR | 1 |
Sargent, DJ | 1 |
Nelson, GD | 1 |
Alberts, SR | 1 |
Sinicrope, FA | 1 |
Goldberg, RM | 1 |
Limburg, PJ | 1 |
Thibodeau, SN | 1 |
Grothey, A | 1 |
Hubbard, JM | 1 |
Chan, E | 1 |
Nair, S | 1 |
Berenberg, JL | 1 |
McWilliams, RR | 1 |
Rocha, C | 1 |
Papon, L | 1 |
Cacheux, W | 1 |
Marques Sousa, P | 1 |
Lascano, V | 1 |
Tort, O | 1 |
Giordano, T | 1 |
Vacher, S | 1 |
Lemmers, B | 1 |
Mariani, P | 1 |
Meseure, D | 1 |
Medema, JP | 1 |
Bièche, I | 1 |
Hahne, M | 1 |
Janke, C | 1 |
Fan, K | 1 |
Li, N | 1 |
Qi, J | 1 |
Yin, P | 1 |
Zhao, C | 1 |
Wang, L | 1 |
Li, Z | 1 |
Zha, X | 1 |
Chattopadhyay, N | 1 |
Berger, AJ | 1 |
Koenig, E | 1 |
Bannerman, B | 1 |
Garnsey, J | 1 |
Bernard, H | 1 |
Hales, P | 1 |
Maldonado Lopez, A | 1 |
Yang, Y | 1 |
Donelan, J | 1 |
Jordan, K | 1 |
Tirrell, S | 1 |
Stringer, B | 1 |
Xia, C | 1 |
Hather, G | 1 |
Galvin, K | 1 |
Manfredi, M | 1 |
Rhodes, N | 1 |
Amidon, B | 1 |
Ducker, GS | 1 |
Chen, L | 1 |
Morscher, RJ | 1 |
Ghergurovich, JM | 1 |
Esposito, M | 1 |
Teng, X | 1 |
Kang, Y | 1 |
Rabinowitz, JD | 1 |
Riscal, R | 1 |
Schrepfer, E | 1 |
Arena, G | 1 |
Cissé, MY | 1 |
Bellvert, F | 1 |
Heuillet, M | 1 |
Rambow, F | 1 |
Bonneil, E | 1 |
Sabourdy, F | 1 |
Vincent, C | 1 |
Ait-Arsa, I | 1 |
Levade, T | 1 |
Thibaut, P | 1 |
Marine, JC | 1 |
Portais, JC | 1 |
Sarry, JE | 1 |
Le Cam, L | 1 |
Linares, LK | 1 |
Liu, Y | 1 |
Wang, SQ | 1 |
Long, YH | 1 |
Chen, S | 1 |
Li, YF | 1 |
Zhang, JH | 1 |
Li, Y | 1 |
Tan, T | 1 |
Zheng, J | 1 |
Zhang, C | 1 |
Cho, JK | 1 |
Chun, C | 1 |
Kuh, HJ | 1 |
Song, SC | 1 |
Duan, X | 1 |
Li, H | 1 |
Chen, H | 1 |
Wang, Q | 1 |
Gross, I | 1 |
Lhermitte, B | 1 |
Domon-Dell, C | 1 |
Duluc, I | 1 |
Martin, E | 1 |
Gaiddon, C | 1 |
Kedinger, M | 1 |
Freund, JN | 1 |
Houli, N | 1 |
Loh, SW | 1 |
Giraud, AS | 1 |
Baldwin, GS | 2 |
Shulkes, A | 2 |
Chattopadhyay, S | 1 |
Zhao, R | 1 |
Krupenko, SA | 1 |
Krupenko, N | 1 |
Goldman, ID | 1 |
Arakawa, Y | 1 |
Suzuki, H | 1 |
Saito, S | 1 |
Yamada, H | 1 |
Daugherty, SE | 1 |
Platz, EA | 1 |
Shugart, YY | 1 |
Fallin, MD | 1 |
Isaacs, WB | 1 |
Chatterjee, N | 1 |
Welch, R | 1 |
Huang, WY | 1 |
Hayes, RB | 1 |
Wilson, KJ | 1 |
Witter, DJ | 1 |
Grimm, JB | 1 |
Siliphaivanh, P | 1 |
Otte, KM | 1 |
Kral, AM | 1 |
Fleming, JC | 1 |
Harsch, A | 1 |
Hamill, JE | 1 |
Cruz, JC | 1 |
Chenard, M | 1 |
Szewczak, AA | 1 |
Middleton, RE | 1 |
Hughes, BL | 1 |
Dahlberg, WK | 1 |
Secrist, JP | 1 |
Miller, TA | 1 |
Claque, MB | 1 |
Carmichael, MJ | 1 |
Satoh, M | 1 |
Cherian, MG | 1 |
Imura, N | 1 |
Shimizu, H | 1 |
Gan, LS | 1 |
Niederer, T | 1 |
Eads, C | 1 |
Thakker, D | 1 |
Capaccioli, S | 1 |
Di Pasquale, G | 1 |
Mini, E | 1 |
Mazzei, T | 1 |
Quattrone, A | 1 |
Furuishi, K | 1 |
Misumi, S | 1 |
Shoji, S | 1 |
Lang, SM | 1 |
Heinzlmann, M | 1 |
Stratakis, DF | 1 |
Teschauer, W | 1 |
Loeschke, K | 1 |
Hofman, P | 1 |
Selva, E | 1 |
Le Negrate, G | 1 |
d'Andrea, L | 1 |
Guérin, S | 1 |
Rossi, B | 1 |
Auberger, P | 1 |
Paranavitana, CM | 1 |
Lozonschi, L | 1 |
Sunamura, M | 1 |
Kobari, M | 1 |
Egawa, S | 1 |
Ding, L | 1 |
Matsuno, S | 1 |
Aly, A | 1 |
Saravis, CA | 2 |
Oh, SK | 2 |
Pusztaszeri, G | 2 |
Doos, WG | 1 |
Zamcheck, N | 2 |
Doos, W | 1 |
Smith, TK | 1 |
Gibson, CL | 1 |
Howlin, BJ | 1 |
Pratt, JM | 1 |
Striebel, JP | 1 |
Saeger, HD | 1 |
Ritz, R | 1 |
Leweling, H | 1 |
Holm, E | 1 |
Bibby, MC | 1 |
Double, JA | 1 |
1 trial available for glycine and Colonic Neoplasms
Article | Year |
---|---|
Variants in the alpha-Methylacyl-CoA racemase gene and the association with advanced distal colorectal adenoma.
Topics: Adenoma; Aged; Alleles; Anti-Inflammatory Agents, Non-Steroidal; Aspartic Acid; Case-Control Studies | 2007 |
34 other studies available for glycine and Colonic Neoplasms
Article | Year |
---|---|
Use of STAT6 Phosphorylation Inhibitor and Trimethylglycine as New Adjuvant Therapies for 5-Fluorouracil in Colitis-Associated Tumorigenesis.
Topics: Adjuvants, Pharmaceutic; Animals; Apoptosis; beta Catenin; Cadherins; Carcinogenesis; Cell Adhesion | 2020 |
The evaluation of the anti-cancer activity of ixazomib on Caco2 colon solid tumor cells, comparison with bortezomib.
Topics: Adenocarcinoma; Antineoplastic Agents; Boron Compounds; Bortezomib; Caco-2 Cells; Caspase 3; Colonic | 2017 |
Anticancer activity of novel amino acid derivative of palladium complex with phendione ligand against of human colon cancer cell line.
Topics: Animals; Antineoplastic Agents; Cattle; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Coo | 2017 |
HY-1 induces G(2)/M cell cycle arrest in human colon cancer cells through the ATR-Chk1-Cdc25C and Weel pathways.
Topics: Animals; Apoptosis; Ataxia Telangiectasia Mutated Proteins; CDC2 Protein Kinase; cdc25 Phosphatases; | 2013 |
Patient and tumor characteristics and BRAF and KRAS mutations in colon cancer, NCCTG/Alliance N0147.
Topics: Adult; Aged; Aspartic Acid; Clinical Trials, Phase III as Topic; Colonic Neoplasms; DNA Mismatch Rep | 2014 |
Tubulin glycylases are required for primary cilia, control of cell proliferation and tumor development in colon.
Topics: Animals; Blotting, Western; Carcinogens; Cell Proliferation; Cells, Cultured; Cilia; Colon; Colonic | 2014 |
Wnt/β-catenin signaling induces the transcription of cystathionine-γ-lyase, a stimulator of tumor in colon cancer.
Topics: Alkynes; Animals; Binding Sites; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colonic Neopla | 2014 |
KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism.
Topics: Amino Acids; Animals; Antineoplastic Agents; Boron Compounds; Carcinoma, Non-Small-Cell Lung; Cell L | 2015 |
Reversal of Cytosolic One-Carbon Flux Compensates for Loss of the Mitochondrial Folate Pathway.
Topics: Aminoimidazole Carboxamide; Carbon; Cell Compartmentation; Cell Proliferation; Colonic Neoplasms; CR | 2016 |
Chromatin-Bound MDM2 Regulates Serine Metabolism and Redox Homeostasis Independently of p53.
Topics: Activating Transcription Factor 4; Animals; Carcinoma, Non-Small-Cell Lung; Carrier Proteins; Cell P | 2016 |
KRASG12 mutant induces the release of the WSTF/NRG3 complex, and contributes to an oncogenic paracrine signaling pathway.
Topics: A549 Cells; Animals; Antineoplastic Agents, Immunological; Cell Line; Cell Line, Tumor; Cell Prolife | 2016 |
[A comparison on radiochemical behavior and biological property of antisense oligonucleotide labeled with technetium-99m by two methods: NHS-MAG3 versus SHNHP].
Topics: Animals; Colonic Neoplasms; Glycine; Humans; Isotope Labeling; Mice; Mice, Inbred BALB C; Niacinamid | 2008 |
Injectable poly(organophosphazene)-camptothecin conjugate hydrogels: synthesis, characterization, and antitumor activities.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Colonic Neoplasms; Drug Stability; D | 2012 |
Discrimination of colon cancer stem cells using noncanonical amino acid.
Topics: Alkynes; Cell Separation; Colonic Neoplasms; Glycine; HCT116 Cells; Humans; Neoplastic Stem Cells | 2012 |
Phosphorylation of the homeotic tumor suppressor Cdx2 mediates its ubiquitin-dependent proteasome degradation.
Topics: Adenocarcinoma; Alanine; Alkaline Phosphatase; Amino Acid Sequence; Amino Acid Substitution; Animals | 2005 |
Mitogenic effects of both amidated and glycine-extended gastrin-releasing peptide in defunctioned and azoxymethane-treated rat colon in vivo.
Topics: Animals; Azoxymethane; Cell Proliferation; Colon; Colonic Neoplasms; Gastrin-Releasing Peptide; Glyc | 2006 |
The inverse relationship between reduced folate carrier function and pemetrexed activity in a human colon cancer cell line.
Topics: Amino Acid Substitution; Antineoplastic Agents; Arginine; Carrier Proteins; Cell Line, Tumor; Coloni | 2006 |
Novel missense mutation of the DNA topoisomerase I gene in SN-38-resistant DLD-1 cells.
Topics: Amino Acid Substitution; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Colonic | 2006 |
Phenylglycine and phenylalanine derivatives as potent and selective HDAC1 inhibitors (SHI-1).
Topics: Acetylation; Amides; Animals; Cell Proliferation; Colonic Neoplasms; Dogs; Enzyme Inhibitors; ERG1 P | 2008 |
15N glycine metabolism.
Topics: Colonic Neoplasms; Glycine; Humans; Kinetics; Rectal Neoplasms | 1982 |
Modulation of resistance to anticancer drugs by inhibition of metallothionein synthesis.
Topics: Alkynes; Animals; Cisplatin; Colonic Neoplasms; Cysteine; Doxorubicin; Drug Resistance; Female; Fibr | 1994 |
Evidence for predominantly paracellular transport of thyrotropin-releasing hormone across CACO-2 cell monolayers.
Topics: 2,4-Dinitrophenol; Adenocarcinoma; Amiloride; Azides; Biological Transport; Cell Line; Cell Membrane | 1993 |
Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum.
Topics: 3T3 Cells; Adenocarcinoma; Animals; Base Sequence; Biological Transport; Cell Line; Colonic Neoplasm | 1993 |
A novel monoclonal antibody to N-myristoyl glycine moiety found a new N-myristoylated HIV-1 p28gag protein in HIV-1-infected cells.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antibody Specificity; Avian Sarcoma Viruses; Cells, | 1996 |
Detection of Ki-ras mutations by PCR and differential hybridization and of p53 mutations by SSCP analysis in endoscopically obtained lavage solution from patients with long-standing ulcerative colitis.
Topics: Aspartic Acid; Biopsy; Case-Control Studies; Cell Transformation, Neoplastic; Codon; Colitis, Ulcera | 1997 |
CD10 inhibitors increase f-Met-Leu-Phe-induced neutrophil transmigration.
Topics: Benzylidene Compounds; Chemotaxis, Leukocyte; Colonic Neoplasms; Drug Synergism; Enzyme Inhibitors; | 1998 |
Non-radioactive detection of K-ras mutations by nested allele specific PCR and oligonucleotide hybridization.
Topics: Alanine; Amino Acid Substitution; Animals; Aspartic Acid; Breast Neoplasms; Codon; Colonic Neoplasms | 1998 |
Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor, KB-R7785, in two tumor models.
Topics: Adenocarcinoma; Animals; Colonic Neoplasms; Glycine; Hydroxamic Acids; Lung Neoplasms; Male; Metallo | 1999 |
Short term infusion of glycine-extended gastrin(17) stimulates both proliferation and formation of aberrant crypt foci in rat colonic mucosa.
Topics: Animals; Azoxymethane; Carcinogens; Cell Division; Colon; Colonic Neoplasms; Gastrins; Glycine; Horm | 2001 |
Tissue localization of zinc glycinate marker and carcinoembryonic antigen by immunofluorescence. I. Preparation of antisera against the zinc glycinate marker.
Topics: Animals; Antibodies, Neoplasm; Carcinoembryonic Antigen; Chromatography, Gel; Colonic Neoplasms; Ele | 1978 |
Present status of the zinc glycinate marker (ZGM).
Topics: Antigens, Neoplasm; Chromatography, Gel; Colonic Neoplasms; Glycine; Humans; Neoplasm Metastasis; Ne | 1978 |
Active transport of amino acids by gamma-glutamyl transpeptidase through Caco-2 cell monolayers.
Topics: Amino Acids; Biological Transport; Biological Transport, Active; Cell Line; Cell Membrane; Colonic N | 1991 |
[Amino acid uptake and release by colorectal cancer in man].
Topics: Aged; Amino Acids; Colonic Neoplasms; Female; Glutamates; Glutamic Acid; Glutamine; Glycine; Humans; | 1986 |
Activity of N-[N'-(2-chloroethyl)-N'-nitrosocarbamoyl]-alanine and derivatives against transplantable adenocarcinomata of the mouse colon (MAC).
Topics: 1,2-Dimethylhydrazine; Adenocarcinoma; Alanine; Animals; Antineoplastic Agents; Colonic Neoplasms; D | 1986 |